Medios Sets Out Ambition 2031 €3.1 Billion Revenue And A Doubling Of EBITDA Adjusted

By Reuters News

Sept 29 (Reuters) - Medios AG ILM1k.DE:

  • SETS OUT AMBITION 2031: €3.1 BILLION REVENUE AND A DOUBLING OF EBITDA ADJUSTED

  • SETS INTERNAL NET DEBT/EBITDA CEILING AT 2.0X

  • NET DEBT/EBITDA AT 1.32X IN H1 2026

  • TARGETS REVENUE GROWTH FROM €2.10 BILLION IN 2025 TO €3.10 BILLION BY 2031

  • CUMULATIVE M&A CAPACITY ABOUT €325 MILLION THROUGH 2031

  • REPORTS 2025 EBITDA ADJUSTED OF €87 MILLION AS BASELINE FOR 2031 TARGET

  • TO OPERATE TWO SEGMENTS: SPECIALTY PHARMA SUPPLY AND COMPOUNDING

  • ANTITRUST CLEARANCES OBTAINED FOR CAESAR & LORETZ ACQUISITION; CLOSING EXPECTED SHORTLY

Further company coverage: [ILM1k.DE]

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.